Jeff Dienhart Named Managing Director of Map of Medicine

Map of MedicineHearst Corporation announced that Jeff Dienhart has been named managing director of Map of Medicine, a subsidiary of Hearst Business Media. Dienhart succeeds Nat Billington, who has decided to leave the company. The appointment was announced today by Frank A. Bennack, Jr., vice chairman and CEO of Hearst Corporation, and Richard P. Malloch, president of Hearst Business Media, and is effective immediately.

Dienhart joins the Map from Groupe Danone, where most recently he was U.K. medical division director, responsible for commercial functions. Dienhart has 17 years of experience with blue-chip life-science companies with a prior background in management consultancy. He has also led various industry and government affairs groups and is the departing British Specialist Nutrition Association (BSNA) Chairman.

"I am very excited that Jeff is joining Map of Medicine," Malloch said. "Map of Medicine's patient pathways, based on the latest clinical evidence, have been used to improve the quality and efficiency of health care in the U.K. Jeff's senior management experience in working across the health care continuum - providers, payers and patients - will be invaluable to the growth of the company."

Regularly used by more than 7,500 clinical staff, Map of Medicine care maps are enabling clinical outcome improvements and productivity savings through local service reconfiguration across a growing range of conditions. Map of Medicine is successfully utilizing its experience gained with clients across the National Health Service (NHS) to simplify services commissioning across care settings, contributing to an improved patient experience. As the NHS faces a period of change, Map of Medicine is well positioned as the solution to address the quality, innovation, productivity and prevention (QIPP) challenge.

"I am delighted to be taking on this new role at this time, as the NHS enters a significant and challenging period of change," Dienhart said. "The Map of Medicine is ideally placed to support the increasing focus on improved productivity and patient outcomes, without sacrificing the overall care environment. We look forward to evolving alongside our health care and IT solutions partners, ensuring that the Map of Medicine's offerings continue to support the design and commissioning of optimum care maps as well as serve as a trusted information resource - leading to the best possible treatment decisions."

Related news articles:

About Map of Medicine
The ideal starting point for defining and communicating services, Map of Medicine is a collection of evidence-based, practice-informed care maps which connect all the knowledge and services around a clinical condition. Map of Medicine care maps can be customised to reflect local needs and practices, offering the opportunity to radically change the way commissioning of health and social care is planned and delivered locally. Map of Medicine is part of Hearst Business Media which is owned by Hearst Corporation, one of the world's largest diversified communications companies. For more information about Map of Medicine, visit www.mapofmedicine.com.

About Hearst Corporation
Hearst Corporation is one of the nation's largest diversified media companies. Its major interests include ownership of 15 daily and 38 weekly newspapers, including the Houston Chronicle, San Francisco Chronicle, San Antonio Express-News and Albany Times Union; nearly 200 magazines around the world, including Good Housekeeping, Cosmopolitan and O, The Oprah Magazine; 29 television stations, which reach a combined 18% of U.S. viewers; ownership in leading cable networks, including Lifetime, A&E, History and ESPN; as well as business publishing, including a minority joint venture interest in Fitch Ratings; Internet and marketing services businesses, television production, newspaper features distribution and real estate.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...